Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Do not leave it sitting on the lab bench while you reconstitute your peptide
PMID: 32682573
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA
Not all patients qualify for all treatments book a free consultation to find out what program is right for you.
The Role of Triple and Quadruple Agonism The concept of cagrilintide dosage with tirzepatide represents potential quadruple pathway activation: GIP pathway (via tirzepatide) GLP-1 pathway (via tirzepatide) Amylin pathway (via cagrilintide) Potential synergistic effects across all three While no clinical data yet exists for this specific combination, the success of dual and triple agonist approaches suggests that carefully designed multi-pathway interventions may represent the future of metabolic medicine
